Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Multiomics reveals multilevel control of renal and systemic metabolism by the renal tubular circadian clock
Yohan Bignon, … , Frédéric Gachon, Dmitri Firsov
Yohan Bignon, … , Frédéric Gachon, Dmitri Firsov
Published March 2, 2023
Citation Information: J Clin Invest. 2023;133(8):e167133. https://doi.org/10.1172/JCI167133.
View: Text | PDF
Research Article Nephrology

Multiomics reveals multilevel control of renal and systemic metabolism by the renal tubular circadian clock

  • Text
  • PDF
Abstract

Circadian rhythmicity in renal function suggests rhythmic adaptations in renal metabolism. To decipher the role of the circadian clock in renal metabolism, we studied diurnal changes in renal metabolic pathways using integrated transcriptomic, proteomic, and metabolomic analysis performed on control mice and mice with an inducible deletion of the circadian clock regulator Bmal1 in the renal tubule (cKOt). With this unique resource, we demonstrated that approximately 30% of RNAs, approximately 20% of proteins, and approximately 20% of metabolites are rhythmic in the kidneys of control mice. Several key metabolic pathways, including NAD+ biosynthesis, fatty acid transport, carnitine shuttle, and β-oxidation, displayed impairments in kidneys of cKOt mice, resulting in perturbed mitochondrial activity. Carnitine reabsorption from primary urine was one of the most affected processes with an approximately 50% reduction in plasma carnitine levels and a parallel systemic decrease in tissue carnitine content. This suggests that the circadian clock in the renal tubule controls both kidney and systemic physiology.

Authors

Yohan Bignon, Leonore Wigger, Camille Ansermet, Benjamin D. Weger, Sylviane Lagarrigue, Gabriel Centeno, Fanny Durussel, Lou Götz, Mark Ibberson, Sylvain Pradervand, Manfredo Quadroni, Meltem Weger, Francesca Amati, Frédéric Gachon, Dmitri Firsov

×

Figure 6

Carnitine metabolism and renal handling in cKOt mice.

Options: View larger image (or click on image) Download as PowerPoint
Carnitine metabolism and renal handling in cKOt mice.
(A) Temporal plot ...
(A) Temporal plot showing the renal carnitine content in Ctrl and cKOt mice. (B) Schematic of renal carnitine synthesis pathway where BBOX1 (surrounded with red) is the rate limiting enzyme. (C) Temporal plots of major renal metabolites (peach), transcripts (yellow) and proteins (green) involved in carnitine synthesis detected in kidneys of Ctrl and cKOt mice. (D) Schematic of renal carnitine handling in proximal tubules: OCTN2 (SLC22A5) transporter (surrounded in red) is rate limiting for apical reabsorption of filtered carnitine. (E) Temporal plots showing the relative expression of renal carnitine transporters in kidneys of Ctrl and cKOt mice. Numbers link components of B to temporal plots. (F–H) Carnitine concentrations in plasma (F) or urine (G) and carnitine-excreted fraction (H) in Ctrl and cKOt mice before DOX treatment (baseline), 3 or 7 days after the beginning of the DOX treatment (3d or 7d DOX), and 2 weeks after the end of DOX treatment (14d post-DOX). (I) Carnitine content in liver, brain, skeletal muscle (right rectus femoris), and heart of Ctrl and cKOt mice 4 weeks after the end of DOX treatment. Throughout the Figure, the rhythmicity model obtained from dryR and Padj value obtained from limma mean expressions comparison in Ctrl and cKOt mice are mentioned on temporal plots. Results in panels F to I are mean ± SEM (n= 4 in each genotype) determined by 2-way ANOVA and Sidak’s multiple comparison posthoc tests. OCT2, organic cation transporter 2 (OCT2); BBOX1, γ-butyrobetaine hydroxylase 1; HTML, hydroxytrimethyllysine; OCTN2, organic cation transporter novel family member 2 (SLC22A5); TMABA, trimethylaminobutyraldehyde; TMABADH, trimethylaminobutyraldehyde dehydrogenase; TMLHA, hydroxyl-trimethyl-lysine aldolase; TMLHE, trimethyl-lysine hydrolase ϵ.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts